The association between short-acting β2-agonist over-prescription, and patient-reported acquisition and use on asthma control and exacerbations : data from Australia

Price, D, Jenkins, C, Hancock, K, Vella, R, Heraud, F, Le Cheng, P, Murray, R B, Beekman, M JHI, Bosnic-Anticevich, S, Botini, F, Carter, V, Catanzariti, A, Doan, J, Fletton, K, Kichkin, A, Le, T, Le Lievre, C E, Lau, C M, Novic, D, Pakos, J, Ranasinghe, K, Roussos, A, Samuel-King, J, Sharma, A, Stewart, D, Willet, B, OPCA Improving Asthma outcomes in Australia Research Group & Bateman, E 2024, 'The association between short-acting β2-agonist over-prescription, and patient-reported acquisition and use on asthma control and exacerbations : data from Australia', Advances in Therapy, vol. 41, pp. 1262–1283. https://doi.org/10.1007/s12325-023-02746-0